Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin

ClinicalTrials.gov ID: NCT06601166

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06601166. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 12:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin: The CONNECT Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or routine care (RC) plus interval blinded CGM wear.

Study identification

NCT ID
NCT06601166
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
DexCom, Inc.
Industry
Enrollment
283 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 15, 2024 (Actual)
Primary completion
May 13, 2026 (Actual)
Completion
Dec 16, 2026 (Estimated)
Last update posted
Aug 11, 2026

2024 – 2026

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
University of Colorado, Anschutz Medical Campus, Department of Family Medicine, Primary Care Diabetes Lab Aurora Colorado 80045 —
Tekton Research Denver Colorado 80238 —
East Coast Institute for Research Lake City Florida 32055 —
Institute of Endocrinology, Diabetes, Health and Hormone Stockbridge Georgia 30281 —
The South Bend Clinic South Bend Indiana 46617 —
International Diabetes Center Saint Louis Park Minnesota 55416 —
Jefferson City Medical Group Jefferson City Missouri 65109 —
East Northport Medical Care East Northport New York 11731 —
Cross Creek Medical Center Fayetteville North Carolina 28304 —
Lucas Research Morehead City North Carolina 28557 —
Alliance Medical Ministry Raleigh North Carolina 27610 —
Centricity Research Columbus Ohio 43213 —
Tekton Research Moore Oklahoma 73160 —
Medical Care-Avacare Elizabethton Tennessee 37643 —
Tekton Research - Austin Austin Texas 78705 —
Texas Tech University Health Sciences Center Lubbock Texas 79430 —
Texas Tech University Health Sciences Center Odessa Texas 79763 —
Cope Family Medicine Ogden Clinic Bountiful Utah 84010 —
Ogden Clinic Grand View Roy Utah 84067 —
Riverside Family Medicine Residency Newport News Virginia 23601 —
Mountain State Diabetes Parkersburg West Virginia 26101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06601166, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.